BioSpace News Archive

Press Releases

Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome

January 8, 2026
·
8 min read
Press Releases

Navigator Medicines Accelerates Anti OX-40L and TNFα Bispecific Antibody Clinical Development Pipeline into Phase 2a and First-in-Human Trials

January 8, 2026
·
5 min read
Press Releases

Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib

January 8, 2026
·
6 min read
Press Releases

Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights

January 8, 2026
·
6 min read
Press Releases

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa

January 8, 2026
·
3 min read
Press Releases

Osel Enters Agreement with SWOG Cancer Research Network for First-Ever Pivotal Trial of a Microbiome-Based Therapy in Oncology

January 8, 2026
·
4 min read
Press Releases

Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue

January 8, 2026
·
6 min read
Press Releases

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

January 8, 2026
·
6 min read
Press Releases

Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders

January 8, 2026
·
3 min read
Press Releases

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

January 8, 2026
·
5 min read